Similar Posts
SVOL: Portfolio Retreats From Equities After Failed Recovery, Correction May Reoccur
This article was written by Follow Harrison is a financial analyst who has been writing on Seeking Alpha since 2018 and has closely followed the market for over a decade. He has professional experience in the private equity, real estate, and economic research industry. Harrison also has an academic background in financial econometrics, economic forecasting,…
1 Canadian Stock That Could Be the Next Big AI Winner
When it comes to artificial intelligence (AI) stocks, many investors might think of start-ups and risky meme stocks. However, there’s one Canadian darling that’s been in the industry indirectly, and now directly, for decades. Yes, decades. That’s OpenText (TSX:OTEX), an AI stock that’s moving quickly into the future. Yet its share price still provides investors…
Emeren Group Ltd (NYSE:SOL) Receives Consensus Rating of "Reduce" from Analysts
Emeren Group Ltd (NYSE:SOL – Get Free Report) has been assigned a consensus rating of “Reduce” from the five ratings firms that are covering the company, Marketbeat reports. Three analysts have rated the stock with a sell rating and two have assigned a buy rating to the company. The average twelv Source link
Ahead of Market: 10 things that will decide stock action on Monday
The Indian benchmark Sensex closed over 1,000 points lower, while the Nifty50 ended below 24,900 on Friday, dragged down by banking and IT stocks amid uncertainty over Federal Reserve interest rate cuts. The 30-share BSE Sensex fell 1,017 points, or 1.24%, to settle at 81,183, while the broader NSE Nifty dropped 293 points, or 1.17%,…
Obesity drugmaker Novo Nordisk cuts 2025 outlook, posts Q1 profit above forecast
Obesity drugmaker Novo Nordisk cuts 2025 outlook, posts Q1 profit above forecast Source link
